SEOUL, Korea, May 23, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a biotechnology firm specializing in molecular diagnostics has once again been recognized for its unique system for diagnosing COVID-19 variants at this year's European Congress of Clinical Microbiology, the ECCMID....
from PR Newswire: https://ift.tt/3fF6Aca
No comments:
Post a Comment